Search research articles
Contact Us
Filters
Showing results (41-50 of 63) with videos related to
Page
of 7
Sort By:
Leukemia & Lymphoma
|
January 22, 2024
Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement
Anath C Lionel, Ashwath Gurumurthi, Ahmed Fetooh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2007
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer
Gary H Lyman, Alok A Khorana, Anna Falanga, et al.
American Journal of Hematology
|
January 25, 2021
Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib
Preetesh Jain, Rashmi Kanagal-Shamanna, Shaojun Zhang, et al.
Molecular Cancer
|
September 26, 2022
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma
Vivian Changying Jiang, Dapeng Hao, Preetesh Jain, et al.
JAMA Oncology
|
July 11, 2024
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled Trial
Chelsea C Pinnix, Bouthaina S Dabaja, Jillian R Gunther, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2022
Impact of an Interdisciplinary Goals-of-Care Program Among Medical Inpatients at a Comprehensive Cancer Center During the COVID-19 Pandemic: A Propensity Score Analysis
David Hui, Nico Nortje, Marina George, et al.
JAMA Network Open
|
September 29, 2020
Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy
Chelsea C Pinnix, Jillian R Gunther, Penny Fang, et al.
Blood Cancer Journal
|
August 3, 2018
History of autoimmune conditions and lymphoma prognosis
Geffen Kleinstern, Matthew J Maurer, Mark Liebow, et al.
Experimental Hematology & Oncology
|
February 10, 2026
Correction: The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma
Fangfang Yan, Vivian Jiang, Alexa Jordan, et al.
Blood Advances
|
June 27, 2020
Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma
Chelsea C Pinnix, Jillian R Gunther, Bouthaina S Dabaja, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 63) with videos related to
Sort By:
Page
of 7
Leukemia & Lymphoma
|
January 22, 2024
Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement
Anath C Lionel, Ashwath Gurumurthi, Ahmed Fetooh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2007
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer
Gary H Lyman, Alok A Khorana, Anna Falanga, et al.
American Journal of Hematology
|
January 25, 2021
Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib
Preetesh Jain, Rashmi Kanagal-Shamanna, Shaojun Zhang, et al.
Molecular Cancer
|
September 26, 2022
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma
Vivian Changying Jiang, Dapeng Hao, Preetesh Jain, et al.
JAMA Oncology
|
July 11, 2024
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled Trial
Chelsea C Pinnix, Bouthaina S Dabaja, Jillian R Gunther, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2022
Impact of an Interdisciplinary Goals-of-Care Program Among Medical Inpatients at a Comprehensive Cancer Center During the COVID-19 Pandemic: A Propensity Score Analysis
David Hui, Nico Nortje, Marina George, et al.
JAMA Network Open
|
September 29, 2020
Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy
Chelsea C Pinnix, Jillian R Gunther, Penny Fang, et al.
Blood Cancer Journal
|
August 3, 2018
History of autoimmune conditions and lymphoma prognosis
Geffen Kleinstern, Matthew J Maurer, Mark Liebow, et al.
Experimental Hematology & Oncology
|
February 10, 2026
Correction: The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma
Fangfang Yan, Vivian Jiang, Alexa Jordan, et al.
Blood Advances
|
June 27, 2020
Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma
Chelsea C Pinnix, Jillian R Gunther, Bouthaina S Dabaja, et al.
Page
of 7